ArticleAnnals of medicine2026

Body mass index and dyslipidemia influence responses to anti-PD-1 immunotherapy in colorectal cancer.

Shi-Hong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.